Table 2.
Additional Trop2-targeted monoclonal antibodies in preclinical development
| Name | Institute/ Company | Reference/ Patent |
|---|---|---|
| OXG-64 | Oncoxx Biotech SRL | WO201089782A1 |
| KD065 | Nanjing KAEDI Biotech | Not applicable |
| Harbour Biomed patent anti-Trop2 antibody | Harbour Biomed | WO2022143670 |
| Kisoji Bio patent anti-Trop2 antibody | Kisoji Biotechnology | WO2023049999 |
| WuXi Biologics patent anti-Trop2 antibody | WuXi Biologics (Shanghai) | WO2022152308 |
| Chia Tai Tianqing Pharma patent anti-Trop2 antibody | Chia Tai Tianqing Pharmaceutical Group | WO2023104080 |
| Biosion patent anti-Trop2 antibody | Biosion | WO2022222992 |
| Zhejiang Nanomab Tech. patent anti-Trop2-antibody | Zhejiang Nanomab Technology Center | WO2023274365 |